Chemopreventive and therapeutic modulation of green tea polyphenols on drug metabolizing enzymes in 4-Nitroquinoline 1-oxide induced oral cancer

Chemico-Biological Interactions

Volumn 172, Issue 3, 2008, Pages 224-234

  Srinivasan, Periasamy ^a,b   Suchalatha, Subramaniyan ^b   Babu, Pon Velayutham Anandh ^b   Devi, Rethinam Sundaresan ^b   Narayan, Shoba ^b   Sabitha, Kuruvimalai Ekambaram ^b   Shyamala Devi, Chennam Srinivasulu ^b  

^a Korea Atomic Energy Research Institute   (South Korea)

^b UNIVERSITY OF MADRAS   (India)

Author keywords

4 Nitroquinoline 1 oxide; Detoxification; Drug metabolizing enzymes; Green tea polyphenols; Oral cancer; Oral squamous cell carcinoma

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ARRYL HYDROCARBON HYDROXYLASE; CYTOCHROME B5; CYTOCHROME B5 REDUCTASE; CYTOCHROME P450; CYTOCHROME P450 REDUCTASE; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; OXYGENASE; POLYPHENOL DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; MALE; MOUTH CARCINOMA; MOUTH CAVITY; NONHUMAN; RAT; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

4-NITROQUINOLINE-1-OXIDE; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROME-B(5) REDUCTASE; CYTOCHROMES B5; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; MALE; MOUTH NEOPLASMS; NAD(P)H DEHYDROGENASE (QUINONE); PHENOLS; PLANT EXTRACTS; RATS; RATS, WISTAR; TEA;

ANIMALIA; RATTUS;

EID: 40949117534     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2008.01.010     Document Type: Article

References (43)

1. Lippman S.M., and Hong W.K. Molecular markers of the risk of oral cancer. N. Engl. J. Med. 344 (2001) 323-1326
2. Jordan R.C., and Daley T. Oral squamous cell carcinoma: new insight. Can. Dental Assoc. 63 (1997) 517-518 521-525
3. McGinnis J.M., and Foege W.H. Actual causes of death in the United States. J. Am. Med. Assoc. 270 (1993) 2207-2212
4. Ko Y.C., Huang Y.L., and Lee C.H. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J. Oral Path. Med. 24 (1995) 450-453
5. Parkin D.M., Whelan S.L., Ferlay J., Raymond L., and Young J. Cancer Incidence in Five Continents, International Agency for Research on Cancer vol. VI (1997), IARC Scientific Publications, Lyon, France pp.143
6. Notani P.N. Epidemiology and prevention of head and neck cancer: a global view. In: Saranath D. (Ed). Contemporary Issues in Oral Cancer (2000), Oxford University Press, New Delhi 1-29
7. Sugimura T. Multistep carcinogenesis: a 1992 prospective. Science 258 (1992) 603-607
8. Stenman G. Malignancy of 4-NQO induced oral squamous cell carcinomas in rat. Acta Otolaryngol. 92 (1981) 557-561
9. Hendler F.J., Yuan B., Oechlsi M.N., Lentseh E.J., Menes J.C., Shum-Siu A., Hu L.H., Hawkins B., and Heniford B.W. In: Waerner J.A., Lippert B.M., and Rudert H.H. (Eds). 4-NQO oral carcinogenesis, a murine model of human head and neck cancer, Head and neck cancer - advances in basic research (1996), Elsevier Science 79-87
10. Parke D.V. The cytochromes P450 and mechanisms of chemical carcinogenesis. Environ. Health Perspect. 102 (1994) 852-853
11. Sreelekha T.T., Ramadas K., Pandey M., Thomas G., Nalinakumari K.R., and Pillai M.R. Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncol. 37 (2001) 593-598
12. Nakachi K., Imai K., Hayashi S., Watanabe J., and Kawajiri K. Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res. 51 (1991) 5177-5180
13. Kong A.N., Yu R., Hebbar V., Chen C., Owuor E., Hu R., Ee R., and Mandlekar S. Signal transduction events elicited by cancer prevention compounds. Mutat. Res. 480 (2001) 231-241
14. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr. Rev. 56 (1998) 317-333
15. Katiyar S.K., and Mukhtar H. Tea in chemoprevention of cancer; epidemiological and experimental studies. Int. J. Oncol. 8 (1996) 221-238
16. Jankun J., Selman S.H., Swiercz R., and Skrzypczak-Jankun E. Why drinking green tea could prevent cancer. Nature 387 (1997) 561
17. Suganuma M., Okabe S., Sueoka N., Sueoka E., Matsuyama S., Imai K., Nakachi K., and Fujiki H. Green tea and cancer chemoprevention. Mutat. Res. 428 (1999) 339-344
18. Srinivasan P., Sabitha K.E., and Shyamaladevi C.S. Modulatory efficacy of green tea polyphenols on glycoconjugates and immunological markers in 4-Nitroquinoline 1-oxide-induced oral carcinogenesis-A therapeutic approach. Chem. Biol. Interact. 162 2 (2006) 149-156
19. Srinivasan P., Sabitha K.E., and Shyamaladevi C.S. Therapeutic efficacy of green tea polyphenols on cellular thiols in 4-Nitroquinoline 1-oxide induced oral carcinogenesis. Chem. Biol. Interact. 149 (2004) 81-87
20. Srinivasan P., Sabitha K.E., and Shyamaladevi C.S. Attenuation of 4-nitroquinoline 1-oxide induced in vitro lipid peroxidation by green tea polyphenols. Life Sci. 12 (2007) 1080-1086
21. Isbrucker R.A., Edwards J.A., Wolz E., Davidovich A., and Bausch J. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2. Dermal, acute and short-term toxicity studies. Food Chem. Toxicol. 44 (2006) 636-650
22. Alvares A.P., and Mannering G.J. Two-substrate kinetics of drug-metabolizing enzyme systems of hepatic microsomes. Mol. Pharm. 6 3 (1970) 206-212
23. Omura T., and Sato R. The carbon monoxide binding pigment of liver microsomes. J. Biol. Chem. 239 (1964) 2370-2378
24. Philips A.H., and Langdon R.G. Hepatic triphospho-pyridine nucleotide cytochrome C reductase. Isolation, characterization and kinetic studies. J. Biol. Chem. 237 (1962) 2562-2660
25. Cummings B.S., Parker J.C., and Lash L.H. Role of cytochrome P450 and glutathione S-transferase alpha in the metabolism and cytotoxicity of trichloroethylene in rat kidney. Biochem. Pharmacol. 59 5 (2000) 531-543
26. Nebert D.W., and Gelboin H.V. Substrate-inducible microsomal aryl hydroxylase in mammalian cell culture. l. Assembly and properties of induced enzyme. J. Biol. Chem. 243 23 (1968) 6242-6249
27. Bock K.W., Burchell B., Ditton G.J., Hanninen O., Mulder G.J., Owens S., Siest G., and Tephyl T.R. UDP-glucuronosyltransferase activities. Guidelines for consistent interim terminology and assay conditions. Biochem. Pharmcol. 32 6 (1983) 953-955
28. Habig W.H., Pabst M.J., and Jacoby B.W. Glutathione S transferase. The first enzymatic step in mercapturic acid formation. J. Biol. Chem. 249 (1974) 1730-1737
29. Ernster L. DT-diaphorase. In: Colowick S.P., Kapalan N.O., Eds Estabrook R.W., and Pullman M.E. (Eds). Methods of enzymology (X). Oxidative and phosphorylation (1967), Academic press, New York and London
30. Lowry O.H., Rusebrough N.J., Farr A.L., and Randall R.J. Protein measurement with folin-phenol reagent. J. Biol. Chem. 193 (1951) 265-275
31. Yoshimura H., Yoshihara S., Koga N., Nagata K., Wada I., Kuroki J., and Hokama Y. Inductive effect on hepatic enzymes and toxicity of congeners of PCBs and PCDFs. Environ. Health Persp. 59 (1985) 113-119
32. Godoy W., Albano R.M., Moraes E.G., Pinho P.R., Nunes R.A., Saito E.H., Higa C., Filho I.M., Kruel C.D., Schirmer C.C., Gurski R., Lang M.A., and Pinto L.F. CYP2A6/2A7 and CYP2E1 expression in human oesophageal mucosa: regional and inter-individual variation in expression and relevance to nitrosamine metabolism. Carcinogenesis 23 4 (2002) 611-616
33. Andreasson L., Bjorlin G., Laurell P., Trell E., and Korsgaard R. Oral and oropharyngeal cancer, aryl hydrocarbon hydroxylase inducibility and smoking. A follow-up study. ORL J. Otorhinolaryngol. Relative Species 47 3 (1985) 131-138
34. Varnes M.E., and Biaglow J.E. Interactions of the carcinogen 4-nitroquinoline 1-oxide with the non-protein thiols of mammalian cells. Cancer Res. 39 8 (1979) 2960-2965
35. Talalay P., Prochaska H.J., and Spencer S.R. Regulation of enzymes that detoxify the electrophile form of chemical carcinogens. Princess Takamatsu Symptoms 21 (1990) 177-187
36. Muto S., Fujita K.I., Yamazaki Y., and Kamataki T. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat. Res. 479 (2001) 197-206
37. Williams S.N., Shih H., Guenette D.K., Brackney W., Denison M.S., Pickwell G.V., and Quattrochi L.C. Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression. Chem. Biol. Interact. 128 (2000) 211-229
38. Talalay P., De Long M.J., and Prochaska H.J. Molecular mechanisms in protection against carcinogenesis. In: Cory J.G., and Slentivanys A. (Eds). Cancer Biology and Therapeutics (1987), Plemim Press, New York 197-216
39. Yu R., Jiao J.J., Duh J.L., Gudehithulu K., Tan T.H., and Kong T.A.N. Activation of mitogen activated protein kinase by green tea polyphenols: potential signaling pathways in the regulation of antioxidant responsive element-mediated Phase II enzyme gene expression. Carcinogenesis 18 (1997) 451-456
40. Embolaa C.W., Sohnb O.S., Fialab E.S., and Weisburger J.H. Induction of UDP-glucuronosyltransferase 1 (UDP-GT1) gene complex by green tea in male F344 rats. Food Chem. Toxicol. 40 (2002) 841-844
41. Qin J., Xie L.-P., Zheng X.-Y., Wang Y.-B., Bai Y., Shen H.-F., Li L.-C., and Dahiya R. A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins Biochem. Biophys. Res. Commun. 354 4 (2007) 852-885
42. Ahmad N., Adhami V.M., Gupta S., Cheng P., and Mukhtar H. Role of the retinoblastoma (PRB)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate. Arch. Biochem. Biophys. 398 1 (2002) 125-131
43. Lim Y.C., Lee S.-H., Song M.H., Yamaguchi K., Yoon J.-H., Choi E.C., and Baek S.J. Growth inhibition and apoptosis by (-)-epicatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells. Eur. J. Cancer 42 18 (2006) 3260-3266